02:04 PM EDT, 04/23/2024 (MT Newswires) -- Abeona Therapeutics ( ABEO ) shares sank nearly 54% amid heavy trading after the company said late Monday that it plans to resubmit its biologic license application for pz-cel after the US Food and Drug Administration has asked for more data.

More than 4.25 million shares traded intraday compared with a daily average of about 370,000.

Tungray Technologies ( TRSG ) said Tuesday it closed its initial public offering of 1.25 million class A ordinary shares priced at $4 apiece for gross proceeds of $5 million.

Shares slumped 28%, with intraday trading volume at over 832,000 versus a daily average of about 3.58 million.

LKQ's (LKQ) Q1 adjusted earnings fell more than the market anticipated, while the growth in its sales missed expectations.

Shares dropped 113% as intraday trading volume soared to more than 5.32 million compared with a daily average of about 1.53 million.

Price: 3.39, Change: -3.97, Percent Change: -53.93